Dan Crippen has held some of the highest appointive offices in government: Domestic Policy Advisor to President Ronald Reagan; Director of the Congressional Budget Office; Executive Director of the National Governors Association; and Economic Advisor and Chief Counsel for Senate Majority Leader Howard Baker.

Paul Irving is a corporate and nonprofit director and advisor to leaders in business, philanthropy, and academia. Irving is a senior advisor at the Milken Institute, a national advisor at Manatt, Phelps & Phillips, a national law and consulting firm, and a distinguished scholar-in-residence at the University of Southern California Leonard Davis School of Gerontology.

Anna Lin-Schweitzer is an associate director with Feeding Change at the Milken Institute. She leads the portfolio's Food Is Medicine (FIM) research, which addresses critical gaps in the FIM ecosystem by advancing policies and actionable solutions to integrate nutrition into health care.

Holly Freishtat is the senior director of Feeding Change at the Milken Institute and leads the food systems portfolio.

Mark Williams is an associate director with the FasterCures team of the Milken Institute. He manages a number of projects aimed at creating a high-functioning biomedical system, including countering antimicrobial resistance, engaging patients within health systems, and fostering innovation and collaboration in medical research.

Raymond Puerini is a director wtih the FasterCures team of Milken Institute Health. He currently leads FasterCures’ nonprofit capacity-building portfolio, which includes The Research Acceleration and Innovation Network (TRAIN), LeadersLink, and the Rare As One Mentorship Program, as well as FasterCures’ patient engagement work.

Amanda Wagner Gee is an associate director at FasterCures, working on issues related to infrastructure and workforce to support clinical research closer to communities and co-leading the ENRICH-CT coalition.

Kristin Schneeman is senior director on the FasterCures team at the Milken Institute, where she oversees most policy and programmatic activities, focused on improving the research and development environment, engaging patients in research and health, and accelerating innovation.